Fierce Pharma’s Rebecca Williamson talks to Alkermes CEO Richard Pops about the latest chapter in the company’s journey, which is seeing it return to ...

HUGE EXPLOSION: Many potentially therapeutic brain molecules are a boon, asserts Richard Pops. Finding ways to sneak therapeutic drugs past the seemingly impenetrable blood-brain barrier -- a tightly ...

Scientific American is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www ...